Hummingbird Bioscience Pte. Ltd., of Singapore, said it completed an extended series A financing round led by Heritas Capital Management and SEEDS Capital, the investment arm of Enterprise Singapore. Hummingbird's existing investors, including Decheng Capital, which led the series A financing round, also participated.